home / stock / sphs / sphs news

SPHS News and Press, Sophiris Bio Inc From 03/13/19

Stock Information
Company Name: Sophiris Bio Inc
Stock Symbol: SPHS
Market: OTC
Website: sophirisbio.com
Menu
SPHS SPHS Quote SPHS Short SPHS News SPHS Articles SPHS Message Board
Get SPHS Alerts

News, Short Squeeze, Breakout and More Instantly...
SPHS - Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate Highlights

SAN DIEGO and VANCOUVER, British Columbia , March 13, 2019 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company," "We" or "Sophiris"), a biopharmaceutical company developing topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the trea...
SPHS - Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer Trial

SAN DIEGO and VANCOUVER, British Columbia , Dec. 17, 2018 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatmen...

SPHS - Today's Research Reports on Stocks to Watch: Opiant Pharmaceuticals and Sophiris Bio

NEW YORK, NY / ACCESSWIRE / August 30, 2018 / Shares of Opiant saw big gains after Wall Street learned that Emergent Biosciences Inc. announced the acquisition of Adapt Pharma® for $635 million. Adapt markets NARCAN® Nasal Spray for the treatment of opioid overdose, for which Opia...

SPHS - Sophiris Bio to Present at the H.C. Wainwright 20th Annual Global Investment Conference

SAN DIEGO and VANCOUVER, British Columbia , Aug. 29, 2018 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for th...
SPHS - Midday Gainers / Losers (08/29/2018)

Gainers: OPNT +50% . IGC +40% . GKOS +36% . EVFM +26% . IPAS +27% . SPHS +27% . AFMD +25% . JMU +19% . YRD +17% . ZYNE +17% . More news on: Opiant Pharmaceuticals, Inc., India Globalization Capital, Inc, Glaukos, Stocks on the move, , Read more ...

SPHS - Premarket Gainers as of 9:05 am (08/29/2018)

OPNT +79%  on EBS takeout of Adapt Pharma. More news on: Opiant Pharmaceuticals, Inc., Glaukos, India Globalization Capital, Inc, Stocks on the move, , Read more ...

Previous 10 Next 10